Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Filings indexed 1,983 across all filing types
Latest filing 2025-07-01 Major Shareholding Noti…
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Indivior PLC. It details the acquisition of voting rights by Barclays PLC, crossing specific regulatory thresholds. This is a standard regulatory disclosure for major shareholding notifications, which corresponds directly to the 'Major Shareholding Notification' category.
2025-07-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content announces the 'TOTAL VOTING RIGHTS AND CAPITAL' as of July 1, 2025, specifying the total number of issued ordinary shares (124,769,820) and confirming no shares are held in Treasury. This notification directly relates to the denominator used by shareholders for disclosure rules (FCA's Disclosure Guidance and Transparency Rule 5.6.1). This type of mandatory, periodic disclosure regarding share capital and voting rights is a standard regulatory announcement. While it touches upon capital structure, it is primarily a regulatory update disseminated via the RNS system. Given the options, 'Regulatory Filings' (RNS) is the most appropriate general category for mandatory, non-specific regulatory updates distributed through the RNS service, especially when a more specific code like SHA (Share Issue/Capital Change) doesn't perfectly fit the context of a routine voting rights notification.
2025-07-01 English
8-K
Regulatory Filings
2025-06-30 English
Indivior Announces Inclusion in US Russell Indexes
Regulatory Filings Classification · 100% confidence The document is an official announcement disseminated via RNS (RNS Number: 8206O) from Indivior PLC, dated June 30, 2025. The content explicitly announces the company's inclusion in the U.S. Russell 2000® and 3000® Indexes as part of the annual reconstitution. This type of announcement, which is a formal notification of a corporate event or status change released through an official news service (like RNS), fits best under the general 'Regulatory Filings' category, as it is not a financial report (10-K, IR, ER), a management change (MANG), or a specific shareholder vote result (DVA). Since it is a general regulatory news service release that doesn't fit the more specific categories like DIV, CAP, or DIRS, RNS is the most appropriate classification.
2025-06-30 English
Indivior Appoints Tony Kingsley to the Board
Board/Management Information Classification · 99% confidence The document is a formal announcement released via RNS (RNS Number: 2545O) on June 25, 2025. The core content is the announcement of the appointment of Tony Kingsley to the Board of Directors as an Independent Non-Executive Director. This directly relates to changes in the company's board of directors or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The presence of RNS boilerplate confirms it is a regulatory announcement, but MANG is more specific to the content.
2025-06-25 English
8-K
Regulatory Filings
2025-06-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.